Widespread shortages of EpiPen, an epinephrine autoinjector for the treatment of anaphylaxis, have been resolved. The Therapeutic Goods Administration (TGA) confirmed this week the supply had returned to normal following a worldwide shortage that lasted almost a year. Issues with overseas manufacturers of the Mylan product in April 2018 had international ramifications, forcing those with…

Read More

Allergies are commonly believed to have no cure. Given a large percentage of the population experiences various allergies, with peanut allergy the number one cause of allergy-induced fatalities, it was only a matter of time before scientists chose to explore ways to treat the serious health problem. Aimmune Therapeutics-funded study (PALISADE) involved almost 500 participants…

Read More

Fish oil supplementation during childhood may offer a protective effect against allergies for children that reside within heavily polluted areas. New Australian research out of the Woolcock Institute of Medical Research, Sydney, has released the finding of a ground-breaking study that paves the way forward for parents to safeguard their children against common childhood allergies.…

Read More